Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, November 7, 2017
[ Tue, Nov 07th 2017
] - WOPRAI
[ Tue, Nov 07th 2017
] - WOPRAI
[ Tue, Nov 07th 2017
] - WOPRAI
[ Tue, Nov 07th 2017
] - WOPRAI
[ Tue, Nov 07th 2017
] - WOPRAI
[ Tue, Nov 07th 2017
] - WOPRAI
[ Tue, Nov 07th 2017
] - WOPRAI
Mon, November 6, 2017
[ Mon, Nov 06th 2017
] - WOPRAI
[ Mon, Nov 06th 2017
] - WOPRAI
[ Mon, Nov 06th 2017
] - WOPRAI
[ Mon, Nov 06th 2017
] - WOPRAI
[ Mon, Nov 06th 2017
] - WOPRAI
[ Mon, Nov 06th 2017
] - WOPRAI
[ Mon, Nov 06th 2017
] - WOPRAI
[ Mon, Nov 06th 2017
] - WOPRAI
[ Mon, Nov 06th 2017
] - WOPRAI
[ Mon, Nov 06th 2017
] - WOPRAI
[ Mon, Nov 06th 2017
] - WOPRAI
[ Mon, Nov 06th 2017
] - WOPRAI
[ Mon, Nov 06th 2017
] - WOPRAI
[ Mon, Nov 06th 2017
] - WOPRAI
Josh Schimmer Downgraded (BLUE) to Hold on, Nov 6th, 2017
Josh Schimmer of Evercore ISI Group, Downgraded "bluebird bio, Inc." (BLUE) to Hold on, Nov 6th, 2017.
Josh has made no other calls on BLUE in the last 4 months.
There are 6 other peers that have a rating on BLUE. Out of the 6 peers that are also analyzing BLUE, 3 agree with Josh's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Upgraded from Sell to Hold on, Friday, November 3rd, 2017
- Biren Amin of "Jefferies" Downgraded from Strong Buy to Hold on, Wednesday, October 11th, 2017
- Vincent Chen of "Bernstein" Initiated at Hold and Held Target at $109 on, Thursday, July 27th, 2017
These are the ratings of the 3 analyists that currently disagree with Josh
- Dane Leone of "BTIG" Upgraded from Hold to Strong Buy on, Thursday, November 2nd, 2017
- Gena Wang of "Barclays" Maintained at Buy with Increased Target to $162 on, Thursday, November 2nd, 2017
- Matthew Luchini of "BMO Capital" Maintained at Buy with Increased Target to $162 on, Monday, October 30th, 2017
